A Review on: Metaverse in Health Care and Pharma
Journal of Community Pharmacy Practice · 2022
DOI: 10.55529/jcpp.31.1.11 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Community Pharmacy Practice, 2022. Verfasst von Athmaja Shetty und 3 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
The metaverse can be seen as the immersive follow-up to the text-and-picture-based Internet of today, where people stare at a screen, ignoring physical reality. The metaverse offers online experiences that are more immersive and engaging than those of the past, a seamless blending of the physical and digital worlds, by taking advantage of modern technologies like artificial intelligence (AI), augmented reality (AR), virtual reality (VR), and ever-increasing connection (like 5G networks). The metaverse has the potential to influence healthcare because of the convergence of three current main technical trends. (a) telepresence, (b) digital twinning, and (c) blockchain. These three ideas could be used to provide whole new methods of providing treatment, potentially reducing costs, and significantly improving patient outcomes. Finally, while advancements in digital healthcare are to be commended for facilitating easier access to care for a larger spectrum of people, it is crucial to take into account the ethical issues that they raise.
Zitieren
APA
Shetty, A., Kulkarni, G. S., SN, R. B., & Paarakh, P. M. (2022). A Review on: Metaverse in Health Care and Pharma. Journal of Community Pharmacy Practice. https://doi.org/10.55529/jcpp.31.1.11
Vancouver
Shetty A, Kulkarni GS, SN RB, Paarakh PM. A Review on: Metaverse in Health Care and Pharma. Journal of Community Pharmacy Practice. 2022. doi:10.55529/jcpp.31.1.11
BibTeX
@article{Shetty2022,
author = {Shetty, Athmaja and Kulkarni, Gururaj S and SN, Rakesh Babu and Paarakh, Padma M},
title = {A Review on: Metaverse in Health Care and Pharma},
journal = {Journal of Community Pharmacy Practice},
year = {2022},
doi = {10.55529/jcpp.31.1.11}
}
EUVIMED